BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gramenzi A, Cursaro C, Margotti M, Balsano C, Spaziani A, Anticoli S, Loggi E, Salerno M, Galli S, Furlini G, Bernardi M, Andreone P. Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: A phase II study. World J Gastroenterol 2009; 15(47): 5946-5952 [PMID: 20014458 DOI: 10.3748/wjg.15.5946]
URL: https://www.wjgnet.com/1007-9327/full/v15/i47/5946.htm
Number Citing Articles
1
Elisabetta Loggi, Carmela Cursaro, Alessandra Scuteri, Elena Grandini, Arianna Martello Panno, Silvia Galli, Giuliano Furlini, Mauro Bernardi, Claudio Galli, Pietro Andreone. Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis CJournal of Clinical Virology 2013; 56(3): 291 doi: 10.1016/j.jcv.2012.11.012
2
Sirio Fiorino, Carmela Cursaro, Stefania Lorenzini, Elisabetta Loggi, Lucia Brodosi, Laura Cattani, Andrea Cuppini, Mauro Bernardi, Pietro Andreone. The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitisItalian Journal of Medicine 2011; 5(2): 82 doi: 10.1016/j.itjm.2011.02.004